Marc Wilson, CFO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 17,867 shares at $42.91 ($748K) on 2024-03-19, disclosed to the SEC on 2024-03-20.
Scheduled sale ($748k) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.14 | 3,983 | $152K | 20.3% |
| 2 | $42.91 | 6,942 | $298K | 39.8% |
| 3 | $42.91 | 6,942 | $298K | 39.8% |
| Total | $41.85 avg | 17,867 | $748K | 100% |
| Filing → |
| CRNX | SELL | 2024-07-17 | $1.4M | — | Filing → |
| CRNX | SELL | 2024-07-02 | $2.8M | — | Filing → |
| CRNX | SELL | 2024-01-04 | $355K | — | Filing → |